Literature DB >> 24499217

On estrogen, cholesterol metabolism, and breast cancer.

Margaret Warner, Jan-Ake Gustafsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24499217     DOI： 10.1056/NEJMcibr1315176

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

Review 1.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

2.  Association between statin use and second cancer risk in breast cancer patients: a nationwide population-based cohort study.

Authors:  Yin-Che Lu; Da-Wei Huang; Pin-Tzu Chen; Ching-Fang Tsai; Mei-Chen Lin; Che-Chen Lin; Shi-Heng Wang; Yi-Jiun Pan
Journal:  Breast Cancer Res Treat       Date:  2020-10-16       Impact factor: 4.872

Review 3.  Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease.

Authors:  Anne Blaes; Anna Prizment; Ryan J Koene; Suma Konety
Journal:  Heart Fail Clin       Date:  2017-04       Impact factor: 3.179

4.  Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol.

Authors:  Yanjing Guo; Meng Zhao; Tao Bo; Shizhan Ma; Zhongshang Yuan; Wenbin Chen; Zhao He; Xu Hou; Jun Liu; Zhenhai Zhang; Qiang Zhu; Qiangxiu Wang; Xiaoyan Lin; Zhongli Yang; Min Cui; Lu Liu; Yujie Li; Chunxiao Yu; Xiaoyi Qi; Qian Wang; Haiqing Zhang; Qingbo Guan; Lifang Zhao; Shimeng Xuan; Huili Yan; Yanliang Lin; Li Wang; Qihang Li; Yongfeng Song; Ling Gao; Jiajun Zhao
Journal:  Cell Res       Date:  2018-12-17       Impact factor: 25.617

Review 5.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

6.  Cholesterol depletion sensitizes gallbladder cancer to cisplatin by impairing DNA damage response.

Authors:  Yonglong Zhang; Yanfeng Liu; Jinlin Duan; Hui Wang; Yuchen Zhang; Ke Qiao; Jian Wang
Journal:  Cell Cycle       Date:  2019-10-10       Impact factor: 4.534

Review 7.  Cardiovascular Disease and Cancer: Is There Increasing Overlap?

Authors:  Logan Vincent; Douglas Leedy; Sofia Carolina Masri; Richard K Cheng
Journal:  Curr Oncol Rep       Date:  2019-04-06       Impact factor: 5.075

8.  Intratumoral Sterol-27-Hydroxylase (CYP27A1) Expression in Relation to Cholesterol Synthesis and Vitamin D Signaling and Its Association with Lethal Prostate Cancer.

Authors:  Nabeela A Khan; Konrad H Stopsack; Emma H Allott; Travis Gerke; Edward L Giovannucci; Lorelei A Mucci; Philip W Kantoff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-03-13       Impact factor: 4.254

Review 9.  Shared Risk Factors in Cardiovascular Disease and Cancer.

Authors:  Ryan J Koene; Anna E Prizment; Anne Blaes; Suma H Konety
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

10.  Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.

Authors:  Banu K Arun; Yun Gong; Diane Liu; Jennifer K Litton; Angelica M Gutierrez-Barrera; J Jack Lee; Lana Vornik; Nuhad K Ibrahim; Terri Cornelison; Gabriel N Hortobagyi; Brandy M Heckman-Stoddard; Kimberly B Koenig; Ricardo R Alvarez; James L Murray; Vicente Valero; Scott M Lippman; Powel Brown; Nour Sneige
Journal:  Breast Cancer Res Treat       Date:  2016-06-10       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.